Amniotic Fluid Embolism and Uterine Atony- Two Case Reports and Literature Review

Marina Pranjic1,2, Barbara Borovac1,2, Toni Juric1,2*, Marko Klaric1,2

¹Clinical Hospital Center Rijeka, Croatia
²Faculty of medicine, University of Rijeka, Croatia.

*Corresponding author

*Toni Juric, Faculty of medicine, University of Rijeka, Croatia.

Abstract

Introduction: Amniotic fluid embolism (AFE) is a life-threatening condition characterized by the entry of amniotic fluid into the maternal circulation, triggering a „cytokine storm “. The incidence of AFE varies across different populations and studies, ranging from 1.9 to 6.1 cases per 100,000 deliveries. AFE can be classified into two clinical types: the cardiopulmonary collapse type (or classic type) and the disseminated intravascular coagulopathy (DIC) type involving atonic bleeding and rapid deterioration of coagulopathy. Here we present two cases of a 38 and 39-year-old multiparous woman who experienced DIC-type AFE during labor, resulting in uterine atony and emergency peripartum hysterectomy.

Reports: We present two cases, first case of a 38-year-old multiparous pregnant woman at 39 weeks gestation who was admitted for induction of labor due to placental disorder, and the second one of a 39-year-old multiparous at 38 weeks gestation who was admitted for induction of labor with due to intrauterine fetal death. In both cases after vaginal delivery and delivery of the placenta, the puerpera developed uterine atony, postpartum hemorrhage and hypovolemic shock with laboratory findings proving disseminated intravascular coagulopathy. Conservative treatment with parenteral fluid resuscitation, transfusion of blood units, fresh frozen plasma, platelets, fibrinogen and uterotonics showed no significant effect and emergency peripartum hysterectomy was performed. Pathohistological examination of the uterus revealed thrombosis of the vascular spaces and amniotic fluid embolism. Both patients were discharged from hospital and a proper recovery was confirmed at follow-up examinations.

Conclusion: Amniotic fluid embolism is a rare and potentially fatal condition. Prompt resuscitative efforts and emergency treatment are crucial for improving maternal and neonatal outcomes.

Introduction

Amniotic fluid embolism (AFE) is a serious and possibly life-threatening condition during labor or early postpartum period. AFE is a clinical diagnosis that is based on the presence of characteristic clinical findings, and should be suspected in pregnant or recently postpartum women who present with sudden appearance of one or more of symptoms: cardiovascular collapse, respiratory difficulties followed with hypoxia, seizures, and disseminated intravascular coagulopathy (DIC)1-3. Although it is a rare condition, the mortality rate remains high, so advances in the understanding of this disorder should be imperative.

Case Presentations

In this report we present two cases of rapidly deteriorating uterine atony caused by amniotic fluid embolism at a tertiary hospital, Clinical Hospital Center Rijeka, Croatia. Both patients suffered from an atypical type of amniotic fluid embolism.

The first case describes 38-year-old multigravida (G2P2) who was admitted at 39 weeks of pregnancy because of a placental disorder. The patient also suffered from anemia during pregnancy, which was treated with oral iron supplements. Due to the favorable obstetric finding, labor was induced with vaginal prostaglandins. Approximately 15 hours after the start of induction, the patient vaginally delivered a male fetus with Apgar scores of 10 at both first and fifth minute. Ten minutes after delivery, intensive uterine bleeding was noticed. The patient had stable vital parameters (blood pressure 111/70 mmHg and pulse 70/min) and treatment with methylergometrine and syntocinon was started, along with intravenous fluid administration. As the aforementioned therapy did not result in adequate uterine tonus or control the bleeding, tranexamic acid and carboprost tromethamine were administered. Although the patient’s vital signs remained stable, her coagulation parameters deteriorated, and bleeding persisted. Laboratory findings showed a fibrinogen level of 1.06 g/L, prothrombin time 0.6, hemoglobin 81 g/L, and hematocrit 0.246 L/L. Two grams of fibrinogen and two units of red blood cells (RBC) transfusion were administered, and after continuous uterine atony and bleeding, the patient was transferred in the operating room where peripartum hysterectomy was performed. Intraoperatively, an additional one gram of fibrinogen, three units of RBCs, four doses of fresh frozen plasma, and intravenous fluids were administered. After the operation, patient was transferred to Intensive Care Unit. Patient was hospitalized for ten days after the operation, after which she was discharged from the hospital. Pathohistological examination of the uterus confirmed the diagnosis of amniotic fluid embolism (Picture 1).

Figure 1: Microscopic image of pathohistological examination of the uterus (Case 1)

Figure 2: Microscopic image of pathohistological examination of the uterus (Case 2)

In the second case, 39-year-old multigravida (G2P2) was admitted to the hospital at 38 weeks of pregnancy due to intrauterine fetal demise (IUFD) after previously uneventful pregnancy. Due to IUFD and favorable obstetric finding, labor was induced with misoprostol. One hour after the induction, uterine bleeding was noticed on one occasion. However, bleeding stopped spontaneously and patient had satisfactory laboratory findings, including hemoglobin value of 130 g/L and fibrinogen value of 4.29 g/L. Five hours after the induction, the patient vaginally delivered female fetus. After the labor, bleeding persisted with rapid deterioration of laboratory parameters (hemoglobin value of 94 g/L, hematocrit 0.278 L/L, fibrinogen value of 0.00 g/L, and prothrombin 0.40) and worsening vital parameters (blood pressure of 70/40 mmHg and pulse 130/min). Uterotonics and intravenous fluid were administered, along with three grams of fibrinogen, two doses of RBC transfusion, two doses of fresh frozen plasma and one dose of thrombocytes.

However, because adequate uterine tonus was not achieved and the patient’s hemodynamic status remained unstable, she was transferred to the operation room where B-Lynch suture and subsequent peripartum hysterectomy were performed. After the operation, patient was admitted to the Intensive Care Unit, where further deterioration of coagulation was noticed. Due to a hematoma identified on MSCT, the patient underwent reoperation for hematoma drainage. An additional ten doses of RBC transfusion, six doses of fresh frozen plasma and three doses of thrombocytes were administered. The patient remained hospitalized for ten days after the operation, after which she was discharged at her own request. Pathohistological exam of the uterus confirmed amniotic fluid embolism (Picture 2).

Meanwhile, fetal autopsy showed multiple factors that lead to intrauterine fetal demise, which included dilatation of the heart, aspiration of amniotic fluid, severe cyanosis, and edema of the brain. Pathohistological exam of the placenta was also performed and showed retroplacental hematoma, intervillous thrombosis and microcalcifications of the placenta.

Discussion

Both of aforementioned cases highlight the importance of early recognition of amniotic fluid embolism as a potential cause of uterine atony and postpartum bleeding, as well as importance of aggressive approach and multidisciplinary team cooperation in order to improve both neonatal and maternal outcomes.

Amniotic fluid embolism is a rare condition, but exact incidence is difficult to estimate, because many studies may overestimate number of AFE cases. However, it is believed that it ranges from 1.9 to 6.1 cases per 100,000 deliveries4-6 with high mortality that ranges from 20 to 60 percent3. Systematic review from Frati et al. determined that incidence of AFE is 5.5 cases per 100,000 deliveries with 24.8 % mortality rate7.

Risk factors associated with the development of amniotic fluid embolism and subsequently uterine atony include maternal age over 35 years, multiparity, induction of labor, placental abnormalities, preeclampsia and eclampsia. cesarean delivery or instrumental vaginal delivery, fetal distress, fetal death, and male fetus3,5,8-10. Both patients that we presented can be associated with these risk factors: both were over 35 years old and were multigravidas, and both labors were induced for different reasons. Even though AFE is a rare condition, it is important to recognize parturient with increased risk of development. The diagnosis is a challenge for clinicians, due to often non-specific symptoms, and definitive diagnosis is often made after pathohistological examination or in the absence of other explanations for said symptoms. Some studies suggested Zinc protorphyrin (ZnCP-1) from fetal meconium and urine, Sialosyl TN (STN), interleukin-6, and tryptase as markers which could help diagnose AFE7.

Because of severity and diagnostic complexity of this condition, Society for Maternal-Fetal Medicine (SMFM) and Amniotic Fluid Embolism Foundation proposed a definition of AFE based on the presence of four diagnostic criteria11:

  1. Sudden onset of cardiorespiratory arrest or hypotension (defined as systolic blood pressure <90 mmHg) with evidence of respiratory compromise such as dyspnea, cyanosis, or peripheral oxygen saturation <90 per cent.
  2. Disseminated intravascular coagulation (DIC)based on the International Society on Thrombosis and Haemostasis (ISTH) scoring system, adapted for pregnancy12: platelet count: >100,000/mL (0 points), <100,000/mL (1 point), <50,000 (2 points); prolonged prothrombin time or international normalized ratio (INR) <25 percent increase (0 points), 25 to 50 percent increase (1 point), >50 percent increase (2 points); and fibrinogen level >200 mg/dL (0 points), <200 mg/dL (1 point). Score of 3 or greater is strong indicator for overt DIC.
  3. Clinical onset of symptoms during labor or within 30 minutes of delivery of placenta.
  4. Absence of fever of (≥38°C) during labor.

All of the aforementioned criteria must be present.

The pathogenesis of AFE is not yet fully understood. Two main theories have been proposed to explain the pathogenesis of the disease13. First is mechanical theory which attributes AFE to a pulmonal mechanical embolism caused by components in amniotic fluid (meconium, mucus, sebum, lanugo). This concept was first introduced in 1941 by Steiner and Lushbaug14. The second theory is the immune-mediated theory, presented in 1995 by Clark et al.15. This theory suggests that AFE is more similar to an anaphylaxis or septic shock-like response, driven by complement activation.  It is currently believed that discontinuity of maternal-fetal interface can lead to the entry of amniotic fluid into the maternal systemic circulation, which can lead to activation of immunological response and release of vasoactive and procoagulant substances16,17. This leads to elevation of pulmonary pressure and, subsequently, pressure in right ventricle, followed by left ventricle and systemic hypotension. The result of this sequence is cardiogenic pulmonary edema and hypoxemic respiratory failure2,15.

Amniotic fluid embolism can be divided into two types, based on clinical presentation: typical and atypical. Typical type presents into three phases: initial respiratory and circulatory distress, followed by coagulation disorders and progression to acute renal failure and acute respiratory distress syndrome (ARDS), followed by cardiopulmonary collapse. Atypical type presents without cardiopulmonary collapse and first symptom is disseminated intravascular coagulopathy (DIC) type involving uterine atony, massive hemorrhage and rapid progression of coagulopathy8.

Once AFE is diagnosed or suspected, treatment must be aggressive and include multidisciplinary approach between obstetrician, anesthesiologist, midwife and other team members.

In cases of cardiorespiratory arrest, cardiopulmonary resuscitation following Advanced Cardiac Life Support protocol for obstetric patients should be started. Furthermore, control of the hemorrhage and reversion of coagulopathy should be obtained, activation of massive transfusion protocol, and delivering the fetus if incident happens before the labor.

Conclusion

Amniotic fluid embolism is a rare and potentially fatal condition. These cases highlight the importance of early recognition and aggressive management of AFE and its complications. Prompt resuscitative efforts and emergency treatment, as well multidisciplinary approach, are crucial for improving maternal and neonatal outcomes.

REFERENCES

  1. Gilmore DA; Wakim ; Secrest J & Rawson R.(2003). Anaphylactoid syndrome of pregnancy: a review of the literature with latest management and outcome data. AANA J. 71:120.
  2. Gist RS; Stafford IP; Leibowitz AB & Beilin Y.(2009). Amniotic fluid embolism. Anesth Analg 108:1559.
  3. Clark SL. Amniotic fluid embolism. Obstet Gynecol 204; 123:337.
  4. Knight M; Berg C & Brocklehurst P. (2012). Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BMC Pregnancy Childbirth. 12:7.
  5. Mazza GR; Youssefzadeh AC & Klar M. (2022). Association of Pregnancy Characteristics and Maternal Mortality With Amniotic Fluid Embolism. JAMA Netw Open. 5:e2242842.
  6. Bonnet MP; Zlotnik D & Saucedo M (2018). Maternal Death Due to Amniotic Fluid Embolism: A National Study in France. Anesth Analg. 126:175.
  7. Frati P; Foldes-Papp Z; Zaami S & Busardo FP. (2014). Amniotic fluid embolism: what level of scientific evidence can be drawn? A systematic review. Curr Pharm Biotechnol. 14(14):1157-62.
  8. Sitaula S; Das D; Sitaula S & Chhetry M. (2020). Amniotic fluid embolism: A rare cause of maternal collapse- A case report. Clin Case Rep. 8(12):3359-3361.
  9. Lawson HW; Atrash HK & Franks AL. (1990). Fetal pulmonary embolism during legal induced abortion in the United States from 1972 to 1985. Am J Obstet Gynecol. 162:986.
  10. Hasaart TH; Essed GG. (1983). Amniotic fluid embolism after transabdominal amniocentesis. Eur J Obstet Gynecol Reprod Biol. 16:25.
  11. Clar SL; Romero R & Dildy GA. (2016). Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol. 215:408.
  12. Toh CH; Hoots WK. (2007). SSC on Disseminated Intravascular Coagulation of the ISTH. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost. 5:604.
  13. Yang RL; Lang MZ; Li H & Qiao XM. (2021). Immune storm and coagulation storm in the pathogenesis of amniotic fluid embolism. Eur Rev Med Pharmacol Sci. 25(4):1796-1803.
  14. Steiner PE; Lushbaugh CC. (1986). Landmark article, Oct. 1941: Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpect- ed deaths in obstetrics. By Paul E. Steiner and C. C. Lushbaugh. JAMA. 255: 2187-2203.
  15. Clark SL; Hankins GD & Dudley DA (1995). Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol. 172:1158.
  16. Society for Maternal-Fetal Medicine (SMFM). Electronic adress: pubs@smfm.org, Pacheco LD; Saade G. (2016) Amniotic fluid embolism: diagnosis and management. Am J Obstet Gynecol. 215:B16.
  17. Sultan P; Seligman K & Carvalho B. (2016). Amniotic fluid embolism: update and review. Curr Opin Anaesthesiol. 29:288.
TOP